Your browser doesn't support javascript.
loading
Germline-driven replication repair-deficient high-grade gliomas exhibit unique hypomethylation patterns.
Dodgshun, Andrew J; Fukuoka, Kohei; Edwards, Melissa; Bianchi, Vanessa J; Das, Anirban; Sexton-Oates, Alexandra; Larouche, Valérie; Vanan, Magimairajan I; Lindhorst, Scott; Yalon, Michal; Mason, Gary; Crooks, Bruce; Constantini, Shlomi; Massimino, Maura; Chiaravalli, Stefano; Ramdas, Jagadeesh; Mason, Warren; Ashraf, Shamvil; Farah, Roula; Van Damme, An; Opocher, Enrico; Hamid, Syed Ahmer; Ziegler, David S; Samuel, David; Cole, Kristina A; Tomboc, Patrick; Stearns, Duncan; Thomas, Gregory A; Lossos, Alexander; Sullivan, Michael; Hansford, Jordan R; Mackay, Alan; Jones, Chris; Jones, David T W; Ramaswamy, Vijay; Hawkins, Cynthia; Bouffet, Eric; Tabori, Uri.
Afiliación
  • Dodgshun AJ; Children's Haematology/Oncology Centre, Christchurch Hospital and University of Otago Christchurch, 2 Riccarton Ave, Christchurch, 8041, New Zealand. andrew.dodgshun@cdhb.health.nz.
  • Fukuoka K; Division of Haematology/Oncology, The Hospital for Sick Children, 555 University Ave, Toronto, ON, M5G 1X8, Canada.
  • Edwards M; Division of Haematology/Oncology, The Hospital for Sick Children, 555 University Ave, Toronto, ON, M5G 1X8, Canada.
  • Bianchi VJ; The Arthur and Sonia Labatt Brain Tumour Research Centre, The Hospital for Sick Children, 555 University Ave, Toronto, ON, M5G 1X8, Canada.
  • Das A; Division of Haematology/Oncology, The Hospital for Sick Children, 555 University Ave, Toronto, ON, M5G 1X8, Canada.
  • Sexton-Oates A; Murdoch Children's Research Institute, The Royal Children's Hospital, 50 Flemington Rd, Parkville, VIC, 3052, Australia.
  • Larouche V; Université Laval, 2325 Rue de l'Université, Québec, QC, G1V 0A6, Canada.
  • Vanan MI; Cancer Care Manitoba and University of Manitoba, 675 McDermot Ave, Winnipeg, MB, R3E 0V9, Canada.
  • Lindhorst S; Medical University of South Carolina, 171 Ashley Ave Suite 419, MSC 403, Charleston, SC, 29425, USA.
  • Yalon M; Sheba Medical CenterSheba Medical Center, Derech Sheba 2, Tel Hashomer, Ramat Gan, Israel.
  • Mason G; Children's Hospital of Pittsburgh of University of Pittsburgh Medical Center, 4401 Penn Ave, Pittsburgh, PA, 15224, USA.
  • Crooks B; IWK Health Centre, 5850-5980 University Avenue, Halifax, NS, Canada.
  • Constantini S; Tel Aviv Sourasky Medical Center, Weizmann St 6, Tel Aviv-Yafo, Israel.
  • Massimino M; Fondazione IRCCS Istituto Nazionale dei Tumori, Via Giacomo Venezian, 1, 20133, Milano, MI, Italy.
  • Chiaravalli S; Fondazione IRCCS Istituto Nazionale dei Tumori, Via Giacomo Venezian, 1, 20133, Milano, MI, Italy.
  • Ramdas J; Geisinger Medical Center, 100 N. Academy Ave, Danville, PA, 17822, USA.
  • Mason W; Princess Margaret Cancer Centre, 610 University Ave, Toronto, ON, M5G 2C1, Canada.
  • Ashraf S; The Indus Hospital, Korangi, 75190, Karachi, Pakistan.
  • Farah R; LAU Medical Center Rizk Hospital, Zahra Street, Achrafieh, Beirut, Lebanon.
  • Van Damme A; St Luc University Hospital Université Catholique de Louvain, 10 Avenue Hippocrate, 1200, Brussels, Belgium.
  • Opocher E; Azienda Ospedaliera di Padova, via Giustiniani n.2, 35121, Padova, PD, Italy.
  • Hamid SA; The Indus Hospital, Korangi, 75190, Karachi, Pakistan.
  • Ziegler DS; Sydney Children's Hospital, High St, Randwick, NSW, 2031, Australia.
  • Samuel D; Valley Children's Hospital, 9300 Valley Children's Pl, Madera, CA, 93636, USA.
  • Cole KA; Children's Hospital of Philadelphia and University of Pennsylvania, 3401 Civic Center Blvd, Philadelphia, PA, 19104, USA.
  • Tomboc P; WVU Medicine Children's Hospital, 1 Medical Center Dr, Morgantown, WV, 26505, USA.
  • Stearns D; University Hospitals Cleveland, 2101 Adelbert Rd, Cleveland, OH, 44106, USA.
  • Thomas GA; Oregon Health and Science University, 3181 S.W. Sam Jackson Park Rd, Portland, OR, 97239, USA.
  • Lossos A; Hadassah Medical Center and the Hebrew University, POB 12000, 91120, Jerusalem, Israel.
  • Sullivan M; The Royal Children's Hospital, 50 Flemington Rd, Parkville, VIC, 3052, Australia.
  • Hansford JR; The Royal Children's Hospital, 50 Flemington Rd, Parkville, VIC, 3052, Australia.
  • Mackay A; Institute of Cancer Research, 15 Cotswold Road, Sutton, London, SM2 5NG, UK.
  • Jones C; Institute of Cancer Research, 15 Cotswold Road, Sutton, London, SM2 5NG, UK.
  • Jones DTW; Hopp Children's Cancer Center Heidelberg (KiTZ), German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120, Heidelberg, Germany.
  • Ramaswamy V; Division of Haematology/Oncology, The Hospital for Sick Children, 555 University Ave, Toronto, ON, M5G 1X8, Canada.
  • Hawkins C; Division of Haematology/Oncology, The Hospital for Sick Children, 555 University Ave, Toronto, ON, M5G 1X8, Canada.
  • Bouffet E; Division of Haematology/Oncology, The Hospital for Sick Children, 555 University Ave, Toronto, ON, M5G 1X8, Canada.
  • Tabori U; Division of Haematology/Oncology, The Hospital for Sick Children, 555 University Ave, Toronto, ON, M5G 1X8, Canada. uri.tabori@sickkids.ca.
Acta Neuropathol ; 140(5): 765-776, 2020 11.
Article en En | MEDLINE | ID: mdl-32895736
Replication repair deficiency (RRD) leading to hypermutation is an important driving mechanism of high-grade glioma (HGG) occurring predominantly in the context of germline mutations in RRD-associated genes. Although HGG presents specific patterns of DNA methylation corresponding to oncogenic mutations, this has not been well studied in replication repair-deficient tumors. We analyzed 51 HGG arising in the background of gene mutations in RRD utilizing either 450 k or 850 k methylation arrays. These were compared with HGG not known to be from patients with RRD. RRD HGG harboring secondary mutations in glioma genes such as IDH1 and H3F3A displayed a methylation pattern corresponding to these methylation subgroups. Strikingly, RRD HGG lacking these known secondary mutations clustered together with an incompletely described group of HGG previously labeled "Wild type-C" or "Paediatric RTK 1". Independent analysis of two comparator HGG cohorts showed that other RRD/hypermutant tumors clustered within these subgroups, suggesting that undiagnosed RRD may be driving some HGG clustering in this location. RRD HGG displayed a unique CpG Island Demethylator Phenotype in contrast to the CpG Island Methylator Phenotype described in other cancers. Hypomethylation was enriched at gene promoters with prominent demethylation in genes and pathways critical to cellular survival including cell cycle, gene expression, cellular metabolism, and organization. These data suggest that methylation arrays may provide diagnostic information for the detection of RRD HGG. Furthermore, our findings highlight the unique natural selection pressures in these highly dysregulated, hypermutant cancers and provide the novel impact of hypermutation and RRD on the cancer epigenome.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Encefálicas / Metilación de ADN / Reparación del ADN / Trastornos por Deficiencias en la Reparación del ADN / Glioma Límite: Adolescent / Adult / Child / Child, preschool / Female / Humans / Male Idioma: En Revista: Acta Neuropathol Año: 2020 Tipo del documento: Article País de afiliación: Nueva Zelanda

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Encefálicas / Metilación de ADN / Reparación del ADN / Trastornos por Deficiencias en la Reparación del ADN / Glioma Límite: Adolescent / Adult / Child / Child, preschool / Female / Humans / Male Idioma: En Revista: Acta Neuropathol Año: 2020 Tipo del documento: Article País de afiliación: Nueva Zelanda